Categories: Philippines

COVID-19 vaccine in Philippines by 2021, says FDA

METRO MANILA – The Food and Drug Administration (FDA) has assured the public that before the vaccine be made available, the government will make sure the public safety is the utmost priority and that caution will be strictly observed in the vaccine registration.

The FDA is expecting a vaccine to be approved for use in the country by April 2021.

According to FDA director general Eric Domingo, the agency will practive ‘very strict’ protocols in the human trials as the vaccines does not exist yet as of the moment.

Domingo said that if the vacinnes are made available, Healthy people will be the first to be vaccinated and that clinical trials maybe conducted by the local governments as long as they are given the FDA clearance.

All clinical trials must go through the approval of Inter-Agency Task Force. FDA said they haven’t received any application for a vacinne to be registered.

The agency said that it is expecting vacinnes to complete the phase 3 trials by December and the possibility of an FDA approved vaccine in the first quarter of 2021.

Given that it usually takes 45-60 days to get the approval from their own country or the World Health Organization, FDA is expecting that in the best scenario, there is a possibility that there will be an approved vaccine by April 2021. Department of Science and Technology (DOST) Secretary Fortunato dela Peña said that Philippines has 6 Confidentiality Data Agreements (CDA) with pharmaceutical companies abroad.

Related Article : https://www.theasianaffairs.com/philippines/2020/09/24/the-lancet-ph-ranks-66th-out-of-91-countries-in-suppressing-spread-of-covid-19/

Jasmine C.

Mabuhay! An upcoming Newswriter for the Asian Affairs from the Pearl of the Orient - Philippines. Avid follower of celebrity gossips, fashion news. I got into writing so that my fellow Kababayan will be constantly updated with the latest news.

Recent Posts

STI’s Sudden Slowdown: What Singapore’s Market Pullback Reveals About Global Risk Mood

A​‍​‌‍​‍‌​‍​‌‍​‍‌ Market Catching Its Breath The Singapore market turned noticeably quieter after the Straits Times Index (STI) went down, reflecting…

December 6, 2025

Waves of Power: Decoding China’s Bold Fleet Deployment Across East Asian Seas

In​‍​‌‍​‍‌​‍​‌‍​‍‌ response to a sudden and highly visible spike in strategic naval operations, the attention of the world has been…

December 5, 2025

Rising Regional Tensions: How Naval Build-Up Near Taiwan and Japan Is Reshaping East Asian Security

The fast naval build-up in the area of Taiwan and Japan is causing the tension of East Asia to be…

December 5, 2025

Shifting Investment Tides: Asia’s IPO Boom and the AI-Bubble Warning for 2026

The future of Asia in 2026 has an excellent combination of both opportunities and risks: a fresh wave of IPO…

December 5, 2025

When Hunger Has a Gender: Unpacking the Global Food Access Gap Women Face

On​‍​‌‍​‍‌​‍​‌‍​‍‌ a dining table, food from many different cultures may look the same, but that is not the case. After…

December 5, 2025

Asia Power Index 2025: Unmasking the Power Shifts in a US–China Dominated Region — And India’s Strategic Rise

Asia​‍​‌‍​‍‌​‍​‌‍​‍‌ Power Index 2025 reveals a significant change of the region of Asia, transforming the entire continent. While the struggle…

December 5, 2025

This website uses cookies.

Read More